[EN] N-(IMIDAZOLIDIN-2-YLIDENE)-HETEROCYCLOPENTA[b]PYRIDINE DERIVATIVES AS MODULATORS OF ALPHA 2 ADRENERGIC RECEPTORS [FR] DÉRIVÉS DE N-(IMIDAZOLIDIN-2-YLIDÈNE)HÉTÉROCYCLOPENTA[B]PYRIDINE UTILISÉS COMME MODULATEURS DES RÉCEPTEURS ADRÉNERGIQUES ALPHA-2
N-(IMIDAZOLIDIN-2-YLIDENE)-HETEROCYCLOPENTA[b]PYRIDINE DERIVATIVES AS MODULATORS OF ALPHA 2 ADRENERGIC RECEPTORS
申请人:Allergan, Inc.
公开号:EP2736906A1
公开(公告)日:2014-06-04
US8513419B2
申请人:——
公开号:US8513419B2
公开(公告)日:2013-08-20
US8741921B2
申请人:——
公开号:US8741921B2
公开(公告)日:2014-06-03
US9034896B2
申请人:——
公开号:US9034896B2
公开(公告)日:2015-05-19
[EN] N-(IMIDAZOLIDIN-2-YLIDENE)-HETEROCYCLOPENTA[b]PYRIDINE DERIVATIVES AS MODULATORS OF ALPHA 2 ADRENERGIC RECEPTORS<br/>[FR] DÉRIVÉS DE N-(IMIDAZOLIDIN-2-YLIDÈNE)HÉTÉROCYCLOPENTA[B]PYRIDINE UTILISÉS COMME MODULATEURS DES RÉCEPTEURS ADRÉNERGIQUES ALPHA-2
申请人:ALLERGAN INC
公开号:WO2013015984A1
公开(公告)日:2013-01-31
The present invention relates to novel N-(imidazolidin-2-ylidene)-heterocyclo penta[b]pyridine derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals.